Department of Medicine, Western University, London, ON, Canada.
Dept of Medicine, University of Toronto, Toronto, ON, Canada.
J Bone Miner Res. 2022 Dec;37(12):2630-2641. doi: 10.1002/jbmr.4698. Epub 2022 Nov 14.
Chronic hypoparathyroidism (HypoPT) is associated with significant morbidity and impaired quality of life (QoL). The goals of management for chronic HypoPT include improvement in QoL and the prevention of both hypo- and hypercalcemia symptoms and long-term complications. Several groups have provided consensus statements and guidelines on the management of HypoPT; however, due to limited evidence, these recommendations have largely been based on literature reviews, expert opinion, and consensus statements. The objective of this study was to use a systematic approach to describe current practice for the initial assessment and follow-up of patients with chronic HypoPT. We developed a survey asking experts in the field to select the responses that best reflect their current practice. The survey found no differences in responses between nonsurgical and postsurgical patient assessment. For new patients, respondents usually performed an assessment of serum lab profile (calcium [either albumin-adjusted or ionized], magnesium, creatinine, phosphate, 25-hydroxyvitamin D), 24-hour urine (creatinine, calcium), and a renal ultrasound to evaluate for the presence of nephrocalcinosis or nephrolithiasis. For follow-up patients, most respondents perform blood tests and urine tests every 6 months or less frequently. The reported clinical practice patterns for monitoring for complications of chronic HypoPT vary considerably among respondents. Based on the responses in this systematic expert practice survey, we provide practice suggestions for initial assessment and follow-up of patients with chronic HypoPT. In addition, we highlight areas with significant variation in practice and identify important areas for future research. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
慢性甲状旁腺功能减退症(HypoPT)与显著的发病率和生活质量(QoL)受损有关。慢性 HypoPT 管理的目标包括改善 QoL 以及预防低钙血症和高钙血症症状和长期并发症。几个小组已经就 HypoPT 的管理提供了共识声明和指南;然而,由于证据有限,这些建议主要基于文献综述、专家意见和共识声明。本研究的目的是使用系统方法描述慢性 HypoPT 患者初始评估和随访的当前实践。我们设计了一项调查,要求该领域的专家选择最能反映其当前实践的回答。调查发现,非手术和手术后患者评估之间的回答没有差异。对于新患者,受访者通常会评估血清实验室概况(钙[白蛋白校正或离子化]、镁、肌酐、磷酸盐、25-羟维生素 D)、24 小时尿液(肌酐、钙),并进行肾脏超声检查以评估是否存在肾钙质沉着症或肾结石。对于随访患者,大多数受访者每 6 个月或更短时间进行一次血液和尿液检查。监测慢性 HypoPT 并发症的临床实践模式在受访者之间差异很大。基于本次系统专家实践调查的回复,我们为慢性 HypoPT 患者的初始评估和随访提供了实践建议。此外,我们强调了实践中存在显著差异的领域,并确定了未来研究的重要领域。